4
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Assay of a Circulating Sodium Pump Inhibitor in Patients with Essential Hypertension and Normotensive Subjects

, , , , , , & show all
Pages 1209-1219 | Published online: 03 Jul 2009

References

  • Dahl L K, Knudsen K D, Iwai J. Humoral transmission of hypertension: Evidence from parabiosis. Circ Res 1969; 24(25)1–21–1–33, (Suppl. 1)
  • Buckalew V M., Nelson D B. Natriuretic and sodium transport inhibitory activity in plasma of volume-expanded dogs. Kidney Internat 1974; 5: 12–22
  • Gonick H C, Kramer H J, Pavl W, Lu E. Circulating inhibitor of sodium-potassium activated adenosine triphosphatase after expansion of extracellular fluid volume in rats. Clin Sci Mol Med 1977; 53: 329–334
  • Gruber K A, Whitaker J M, Buckalew V M. Endogenous digitalislike substance in plasma of volume-expanded dogs. Nature 1980; 287: 743–745
  • Costa F V, Montebugnoli L, Giordani M F, Vasconi L, Ambrosioni E. Evidence for a plasma factor affecting Na+ cellular transport in genetic normotensive subjects and in borderline hypertensive subjects. Clin Sci 1982; 63: 53s–55s
  • MacGregor G A, Fenton S, Alaghband-Zadeh J, Markandu N, Roulston J, de Wardener H E. Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertension. Br Med J 1981; 283: 1355–1357
  • de Thè H, Devynck M A, Rosenfeld J, Pernollet M G, Elghozi J L, Meyer P. Plasma sodium pump inhibitor in essential hypertension and normotensive subjects with hypertensive heredity. J Cardiovas Pharmacol 1984; 6(Suppl. 1)s49–s54
  • Haddy F J., Overbeck H W. The role of humoral agents in volume expanded hypertension. Life Sci 1976; 19: 935–948
  • Blaustein M P. Sodium ions, calcium ions, blood pressure regulation, and hypertension: A reassessment and a hypothesis. Am J Physiol 1977; 232: c165–c173
  • de Wardener H E, MacGregor G A. Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: Its possible role in essential hypertension. Kidney Internat 1980; 18: 1–4
  • Poston L, Sewell R B, Wilkinson S P, Richardson P J, Williams R, Clarkson E M, MacGregor G A, de Wardener H E. Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J 1981; 282: 847–849
  • Hamlyn J M, Ringel R, Schaeffer J, Levinson P D, Hamilton B P, Kowarski A A, Blaustein M P. A circulating inhibitor of (Na+ + K+) ATPase associated with essential hypertension. Nature 1982; 300: 650–652
  • Blaustein M P, Hamlyn J M. Sodium transport inhibition, cell calcium, and hypertension: The natriuretic hormone/Na+-Ca++ exchange/hypertension hypothesis. Am J Med 1984; 77(4A)45–59
  • Skou J C. The influence of some cations on adenosine triphosphatase from peripheral nerves. Blochim Biophys Acta 1957; 23: 394–401
  • Cantley L C, Cantley L G, Josephson L. A characterization of vanadate interactions with the (Na, K)-ATPase: Mechanistic and regulatory implications. J Biol Chem 1978; 253: 7361–7368
  • Cantley L C, Ferguson J H, Kustin K. Norepinephrine complexes and reduces vanadium (V) to reverse vanadate inhibition of the (Na, K)-ATPase. J Am Chem Soc 1978; 100: 5210–5212
  • Riozzi A, Heagerty A M, Bing R F, Thurston H, Swales J D. Noradrenaline: A circulating inhibitor of sodium transport. Br Med J 1984; 289: 1025–1027
  • Alaghband J, Fenton S, Hancock K, Millett J, de Wardener H E. Evidence that the hypothalamus may be a source of a circulating Na+-K+ ATPase inhibitor. J Endocrinol 1983; 98: 221–226

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.